Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study

Journal of Infectious Diseases

Volumn 208, Issue 9, 2013, Pages 1454-1458

  Wandeler, Gilles ^a,b   Gsponer, Thomas ^b   Bihl, Florian ^c   Bernasconi, Enos ^c   Cavassini, Matthias ^d   Kovari, Helen ^e   Schmid, Patrick ^f   Battegay, Manuel ^g   Calmy, Alexandra ^h   Egger, Matthias ^b   Furrer, Hansjakob ^a   Rauch, Andri ^a   Aubert, V ⁱ   Barth, J ⁱ   Battegay, M ⁱ   Bernasconi, E ⁱ   Boni J ⁱ   Bucher, H C ⁱ   Burton Jeangros, C ⁱ   Calmy, A ⁱ   Cavassini, M ⁱ   Egger, M ⁱ   Elzi, L ⁱ   Fehr, J ⁱ   Fellay, J ⁱ   Francioli, P ⁱ   Furrer, H ⁱ   Fux, C A ⁱ   Gorgievski, M ⁱ   Gunthard H ⁱ   Haerry, D ⁱ   Hasse, B ⁱ   Hirsch, H H ⁱ   Hirschel, B ⁱ   Hosli I ⁱ   Kahlert, C ⁱ   Kaiser, L ⁱ   Keiser, O ⁱ   Kind, C ⁱ   Klimkait, T ⁱ   Kovari, H ⁱ   Ledergerber, B ⁱ   Martinetti, G ⁱ   Martinez De Tejada, B ⁱ   Metzner, K ⁱ   Muller N ⁱ   Nadal, D ⁱ   Pantaleo, G ⁱ   Regenass, S ⁱ   Rickenbach, M ⁱ   Rudin, C ⁱ   Schmid, P ⁱ   Schultze, D ⁱ   Schoni Affolter F ⁱ   Schupbach J ⁱ   Speck, R ⁱ   Taffe P ⁱ   Tarr, P ⁱ   Telenti, A ⁱ   Trkola, A ⁱ   Vernazza, P ⁱ   Weber, R ⁱ   Yerly, S ⁱ   more..

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ NONE

Author keywords

anti hepatitis B core antigen alone; antiretroviral therapy outcomes; hepatitis B infection; immunological recovery

Indexed keywords

EID: 84885405956     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit351     Document Type: Article

References (15)

1. Chun HM, Roediger MP, Hullsiek KH, et al. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis 2012; 205:185-93
2. Peters PJ, Marston BJ. Preventing deaths in persons with HIV/hepatitis B virus coinfection: A call to accelerate prevention and treatment efforts. J Infect Dis 2012; 205:166-8
3. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: A cohort study and meta-Analysis. Clin Infect Dis 2009; 48:1763-71
4. Falade-Nwulia O, Seaberg EC, Rinaldo CR, Badri S, Witt M, Thio CL. Comparative risk of liver-related mortality from chronic hepatitis B versus chronic hepatitis C virus infection. Clin Infect Dis 2012; 55: 507-13
5. Schoeni-Affolter F, Ledergerber B, Rickenbach M, et al. Cohort profile: The Swiss HIV Cohort study. Int J Epidemiol 2010; 39:1179-89
6. Nash D, Katyal M, Brinkhof MW, et al. Long-Term immunologic response to antiretroviral therapy in low-income countries: A collaborative analysis of prospective studies. AIDS 2008; 22:2291-302
7. Huttner AC, Kaufmann GR, Battegay M, Weber R, Opravil M. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy. AIDS 2007; 21:939-46
8. Hoffmann CJ, Charalambous S, Martin DJ, et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008; 47:1479-85
9. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19: 593-601
10. LawWP, Duncombe CJ, Mahanontharit A, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS 2004; 18:1169-77
11. Idoko J, Meloni S, Muazu M, et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis 2009; 49:1268-73
12. Nebbia G, Peppa D, Schurich A, et al. Upregulation of the tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 2012; 7:e47648
13. McCune JM. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 2001; 410:974-9
14. Lacombe K, Gozlan J, Boelle PY, et al. Long-Term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate. AIDS 2005; 19:907-15
15. Grob P, Jilg W, Bornhak H, et al. Serological pattern "anti-HBc alone": Report on a workshop. J Med Virol 2000; 62:450-5